NCT04575311View on ClinicalTrials.gov

A Study to Investigate the Pharmacokinetic Profile of Oral AB680 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 20, 2020

Primary Completion Date

September 22, 2021

Study Completion Date

September 22, 2021

Conditions
Healthy Volunteers
Interventions
DRUG

AB680

AB680 is a Cluster of Differentiation (CD)73 Inhibitor

OTHER

Placebo

Matching Placebo

Trial Locations (1)

Unknown

Nucleus Network, Melbourne

Sponsors
All Listed Sponsors
lead

Arcus Biosciences, Inc.

INDUSTRY

NCT04575311 - A Study to Investigate the Pharmacokinetic Profile of Oral AB680 in Healthy Volunteers | Biotech Hunter | Biotech Hunter